Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigen

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Shahbazi Gahrouei, Daryoush ^a   Abdolahi, Mohammad ^b   Zarkesh Esfahani, Sayyed Hamid ^c   Laurent, Sophie ^d   Sermeus, Corine ^d   Gruettner, Cordula ^e  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF MONS   (Belgium)

^e MICROMOD PARTIKELTECHNOLOGIE GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FUNCTIONALIZED MAGNETIC NANOPARTICLE; MAGNETIC NANOPARTICLE; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; CANCER ANTIBODY; MAGNETITE NANOPARTICLE; TUMOR ANTIGEN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL SEPARATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; IN VITRO STUDY; MAGNETIC FIELD; PARTICLE SIZE; PROSTATE CANCER; QUANTITATIVE ANALYSIS; CHEMISTRY; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CELL SEPARATION; HUMANS; MAGNETITE NANOPARTICLES; MALE; PROSTATIC NEOPLASMS;

EID: 84874602145     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/349408     Document Type: Article

References (28)

1. Chen L., Liu R., Liu Z. P., Li M., Aihara K., Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Scientific Reports 2012 2 342 10.1038/srep00342
2. Luna-Coronell J. A., Syed P., Sergelen K., Gyurján I., Weinhäusel A., The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics. Journal of Proteomics 2012 76 102 115 10.1016/j.jprot.2012.07.022
3. Lee H. J., Wark A. W., Corn R. M., Microarray methods for protein biomarker detection. Analyst 2008 133 8 975 983 2-s2.0-47749102990 10.1039/b717527b (Pubitemid 352033083)
4. Simon R., Genomic biomarkers in predictive medicine: an interim analysis. EMBO Molecular Medicine 2011 3 8 429 435 2-s2.0-79960953818 10.1002/emmm.201100153
5. Magni F., van der Burgt Y. E., Chinello C., Mainini V., Gianazza E., Squeo V., Deelder A. M., Kienle M. G., Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry. Blood Transfusion 2010 8 supplement 3 s92 s97 10.2450/2010.015S
6. Hall J. C., Casciola-Rosen L., Rosen A., Altered structure of autoantigens during apoptosis. Rheumatic Disease Clinics of North America 2004 30 3 455 471 2-s2.0-3142757107 10.1016/j.rdc.2004.04.012 (Pubitemid 38916996)
7. Belov L., Zhou J., Christopherson R. I., Cell surface markers in colorectal cancer prognosis. International Journal of Molecular Sciences 2011 12 1 78 113 2-s2.0-79251612229 10.3390/ijms12010078
8. Schrevel M., Karim R., ter Haar N. T., van der Burg S. H., Trimbos J. B., Fleuren G. J., Gorter A., Jordanova E. S., CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients. British Journal of Cancer 2012 106 9 1520 1525 10.1038/bjc.2012.110
9. Pagès F., Galon J., Dieu-Nosjean M. C., Tartour E., Sautès-Fridman C., Fridman W. H., Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010 29 8 1093 1102 2-s2.0-77649193013 10.1038/onc.2009.416
10. Holmes K., Lantz L. M., Fowlkes B. J., Schmid I., Giorgi J. V., Preparation of cells and reagents for flow cytometry. Current Protocols in Immunology 2001 5 5.3 2-s2.0-43549117484
11. + T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting. Journal of Translational Medicine 2006 4, article 33 2-s2.0-33749540900 10.1186/1479-5876-4-33 (Pubitemid 44530038)
12. Karl S., Wong R. P., St Pierre T. G., Davis T. M., A comparative study of a flow-cytometry-based assessment of in vitro plasmodium falciparum drug sensitivity. Malaria Journal 2009 8 1, article 294 2-s2.0-74549192880 10.1186/1475-2875-8-294
13. Ranzoni A., Sabatte G., van Ijzendoorn L. J., Prins M. W., One-step homogeneous magnetic nanoparticle immunoassay for biomarker detection directly in blood plasma. ACS Nano 2012 6 4 3134 3141 10.1021/nn204913f
14. Long C. M., Van Laarhoven H. W. M., Bulte J. W. M., Levitsky H. I., Magnetovacci nation as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Research 2009 69 7 3180 3187 2-s2.0-66149142268 10.1158/0008-5472.CAN-08-3691
15. Towner R. A., Smith N., Doblas S., Tesiram Y., Garteiser P., Saunders D., Cranford R., Silasi-Mansat R., Herlea O., Ivanciu L., Wu D., Lupu F., In vivo detection of c-Met expression in a rat C6 glioma model. Journal of Cellular and Molecular Medicine 2008 12 1 174 186 2-s2.0-41149147686 10.1111/j.1582-4934. 2008.00220.x
16. Elsässer-Beile U., Bühler P., Wolf P., Targeted therapies for prostate cancer against the prostate specific membrane antigen. Current Drug Targets 2009 10 2 118 125 2-s2.0-64249119444 10.2174/138945009787354601
17. Bühler P., Wolf P., Elsässer-Beile U., Targeting the prostate-specific membrane antigen for prostate cancer therapy. Immunotherapy 2009 1 3 471 481 2-s2.0-77950401374 10.2217/imt.09.17
18. Shahbazi-Gahrouei D., Rizvi S. M., Williams M. A., Allen B. J., In vitro studies of gadolinium-DTPA conjugated with monoclonal antibodies as cancer-specific magnetic resonance imaging contrast agents. Australasian Physical and Engineering Sciences in Medicine 2002 25 1 31 38 2-s2.0-0036233750 (Pubitemid 34464222)
19. Abdolahi M., Shahbazi-Gahrouei D., Laurent S., Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer. Contrast Media & Molecular Imaging 2013 8 2 175 184
20. Mosmann T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983 65 1-2 55 63 2-s2.0-0021061819 (Pubitemid 14203433)
21. Woźniak J., Two methods for the quantitative analysis of surface antigen expression in acute myeloid leukemia (AML). Folia Histochemica et Cytobiologica 2004 42 3 195 199 2-s2.0-4344652025 (Pubitemid 39144958)
22. Sikora J., Zeromski J., Expression of TCR- ζ chain and apoptosis in subpopulations of tumor-associated lymphocytes (TALs) from malignant pleural effusions. Folia Histochemica et Cytobiologica 2002 40 4 347 351 2-s2.0-0036030928 (Pubitemid 35230050)
23. Serda R. E., Adolphi N. L., Bisoffi M., Sillerud L. O., Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging. Molecular Imaging 2007 6 4 277 288 2-s2.0-34848824998 10.2310/7290.2007.00025 (Pubitemid 47509832)
24. Hoelzer D., Novel antibody-based therapies for acute lymphoblastic leukemia. Hematology/the Education Program of the American Society of Hematology 2011 243 249 10.1182/asheducation-2011.1.243
25. Ren J., Zhang Z., Wang F., Yang Y., Liu Y., Wei G., Yang A., Zhang R., Huan Y., Cui Y., Larson A. C., MRI of prostate stem cell antigen expression in prostate tumors. Nanomedicine 2012 7 5 691 703 10.2217/nnm.11.147
26. Kumar C. S. S. R., Biofunctionalization of Nanomaterials 2005 1st Weinheim, Germany Wiley-VCH
27. Jain K. K., The Handbook of Biomarkers 2010 New York, NY, USA Springer
28. Westmeyer G.G.,Durocher Y.,Jasanoff A.A secreted enzyme reporter system for MRI.Angewandte Chemie International Edition 2010 49 23 3909-3911 2-s2.0-77952977376 10.1002/anie.200906712